La Jolla Spa MD, Inc. v. Avidas Pharmaceuticals, LLC

District Court, S.D. California·Decided October 7, 2019·No. 3:17-cv-01124·Unknown

Opinion

LA JOLLA SPA MD, INC, Case No. 3:17-CV-01124-MMA-WVG

Plaintiff, ORDER DENYING v. DEFENDANT’S MOTION TO DISMISS OR, IN THE ALTERNATIVE, FOR SUMMARY Defendant. JUDGMENT

Doc. No. 96 La Jolla Spa MD, Inc. (“Plaintiff”) filed a Third Amended Complaint (“Complaint”) against Avidas Pharmaceuticals, LLC (“Defendant”) for breach of contract. See Doc. No. 87 (“Compl.”). Defendant filed an Answer. See Doc. No. 90 (“Answer”). Defendant moves to dismiss Plaintiff’s Complaint for lack of subject-matter jurisdiction as well as for failure to state a claim under Federal Rules of Civil Procedure 12(b)(1) and 12(b)(6). See Doc. No. 96. Defendant moves in the alternative for summary judgment under Federal Rule of Civil Procedure 56. See id. Plaintiff filed an opposition to the motion, and Defendant replied. See Doc Nos. 97, 99. The Court found the matter suitable for determination on the papers and without oral argument pursuant to Civil Local Rule 7.1.d.1. See Doc. No. 101. For the reasons set forth below, the Court DENIES Defendant’s motion in its entirety. BACKGROUND1 This action arises out of a contractual relationship between the parties regarding Vitaphenol skincare products that the parties later terminated. The central issues arise from actions after termination of the relationship. Plaintiff and Defendant entered into two separate but related contracts on August 19, 2008, which were signed by both parties by October 14, 2008. Compl. ¶ 2; Compl. Ex. 1, 2; Answer ¶ 2. The first contract was the Sales and Distribution Agreement (“Sales Agreement”). Compl. ¶ 2; Compl. Ex. 1; Answer ¶ 2. The second contract was the Know-How and Trademark License and Purchase Agreement, partially supplemented by the Modified Know-How and Trademark License and Purchase Agreement (collectively referred to as the “Know-How Agreement”). Compl. ¶ 2; Compl. Ex. 2. I. Sales Agreement Terms Under the terms of the Sales Agreement, Defendant “was to pay Plaintiff for the cost of inventory sold plus a royalty of 8%.” Compl. ¶ 5. Defendant had the power to terminate the agreement “upon sixty days prior written notice in the event it determines in its sole discretion that continuation of its efforts to promote and sell the Products is no longer in its best business interests.” Compl. Ex. 1 at 4(c). 20 1 Regarding the motion to dismiss for lack of subject-matter jurisdiction, the Court analyzes a facial attack by accepting the allegations of the complaint as true and drawing all reasonable inferences in favor of Plaintiff. See Doe v. Holy See, 557 F.3d 1066, 1073 (9th Cir. 2009) (per curiam) (citing Wolfe v. Strankman, 392 F.3d 358, 362 (9th Cir. 2004). Because the Court construes the motion to dismiss for failure to state a claim as a motion for judgment on the pleadings, see infra, the Court must accept the complaint’s allegations as true and the answer’s allegations that contradict the complaint’s allegations as false. Hoeft v. Tucson Unified Sch. Dist., 967 F.2d 1298, 1301 n.2 (9th Cir. 1992). Regarding the motion for summary judgment, these material facts are taken from the parties’ separate statements and responses thereto, as well as the supporting declarations and exhibits. Where a material fact is in dispute, it will be so noted. Particular disputed material facts that are not recited in this section may be discussed infra. Facts that are immaterial for purposes of resolving the current Upon early termination, the agreement required the following: In the event of early termination in whole or in respect of any product, Avidas shall return all unsold inventory to YGE or unsold Inventory of terminated product(s) (SKUs) if the Agreement is terminated in respect of fewer than all products. Upon early termination of this Agreement Avidas shall immediately cease its promotional activities for the Vitaphenol Products and discontinue any use of the Vitaphenol and La Jolla Spa MD Trademarks. After any early termination of this Agreement YGB shall retain the right to the Vitaphenol Products but will remove any information bearing Avidas’s Trademarks and logos from Product and Product materials.

Id. at 4(g). The agreement further specified payments and royalties concerning sold inventory by Defendant upon termination: “Upon termination, the provisions of this Agreement concerning payment and royalties on Inventory sold to Avidas’s customers shall continue until such payments have been made.” Id. at 4(h). II. Know-How Agreement Terms Under the terms of the Know-How Agreement, Defendant was obligated to pay for the license of the “know-how” and trademark for Vitaphenol through an 8% royalty payment on all Vitaphenol products until the royalty payments totaled $1,500,000; thereafter, Defendant would then pay a 5% royalty. Compl. ¶¶ 5, 7, 13; Compl. Ex. 2 at 4(a)–(c). The Agreement allowed for Defendant to “transfer[] ownership of, or license[], the Know-How and Vitaphenol trademark,” but required Defendant “to obligate the purchaser or licensee to continue paying such five percent (5%) royalty.” Compl. ¶ 7; Compl. Ex. 2 at 4(b). As with the Sales Agreement, the Know-How Agreement gives Defendant the power to terminate the agreement “upon sixty days prior written notice in the event it determines in its sole discretion that continuation of its efforts to promote and sell the Products is no longer in its best business interest.” Complaint Ex. 2 at 8(b). Upon early termination, the Agreement stated that Defendant shall have the right to dispose of its stock of Product and shall have the right to manufacture such finished Product as may be necessary to balance out inventory or to convert raw materials, or goods in process, into finished goods. All sales made pursuant to this section shall be subject to the payments of royalties as provided above.

Free access — add to your briefcase to read the full text and ask questions with AI

La Jolla Spa MD, Inc. v. Avidas Pharmaceuticals, LLC, (S.D. Cal. 2019).

La Jolla Spa MD, Inc. v. Avidas Pharmaceuticals, LLC (La Jolla Spa MD, Inc. v. Avidas Pharmaceuticals, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

PRATT & OTHERS v. Law & Campbell
13 U.S. 456 (Supreme Court, 1815)
Land v. Dollar
330 U.S. 731 (Supreme Court, 1947)
First Nat. Bank of Ariz. v. Cities Service Co.
391 U.S. 253 (Supreme Court, 1968)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Narayan v. EGL, INC.
616 F.3d 895 (Ninth Circuit, 2010)
Alvera M. Aldabe v. Charles D. Aldabe
616 F.2d 1089 (Ninth Circuit, 1980)
Richard Augustine v. United States
704 F.2d 1074 (Ninth Circuit, 1983)
Brian Barlow v. Officer George Ground, I.D. 9129
943 F.2d 1132 (Ninth Circuit, 1991)
Robin Orr v. Bank of America, Nt & Sa
285 F.3d 764 (Ninth Circuit, 2002)